SciClone Pharmaceuticals (Holdings) Limited

http://www.sciclone.com/

Already a Biomedtracker subscriber? You have access to the full company record through your subscription

Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Deal Watch: Revance To Go Private In Crown Laboratories Buyout

Bookmark

14 Aug 2024
News

By Joseph Haas and Vibha Ravi

Plus deals involving AstraZeneca/Conduit, Recursion/Exscientia, G1/Pharmacosmos, Sanofi/Vir, Passage Bio/GEMMA and Lupin/Evofem. Also including deals in brief.

Deal Watch M & A

Levicept Looks For No Pain, More Gain With Osteoarthritis Offering

Bookmark

08 Aug 2024
Analysis

By Kevin Grogan

The UK firm is weighing up its options for late-stage development of LEVI-04 after unveiling positive Phase II results of Phase II for the neurotrophin-3 inhibitor in moderate-to-severe osteoarthritis.

Neurology Clinical Trials

Stock Watch: Investor Reactions Diverge As J&J And Novartis Report Q2 Results

Bookmark

23 Jul 2024
Opinion

By Andy Smith

Both of the first two companies to report second-quarter financials maintained full-year sales guidance. But while Johnson & Johnson’s investors seemed cheered, Novartis’s may have been concerned about familiar issues.

Stock Watch Sales & Earnings